Poliomyelitis
Symptoms, Doctors, Treatments, Advances & More

Poliomyelitis Overview

Save information for later
Sign Up

Learn About Poliomyelitis

What is the definition of Poliomyelitis?
Poliomyelitis is a viral disease that can affect nerves and can lead to partial or full paralysis. It is caused by infection with the poliovirus which can be spread by direct person-to-person contact, by contact with infected mucus or phlegm from the nose or mouth, or by contact with infected feces. There are three basic patterns of polio infection: subclinical infections, nonparalytic, and paralytic. Symptoms vary based on the pattern of infection and can range from asymptomatic with subclinical Poliomyelitis to partial or full paralysis. Since the development of the polio vaccine, the incidence of the disease has been greatly reduced.
What are the alternative names for Poliomyelitis?
  • Poliomyelitis
  • Infantile paralysis
  • Polio
Who are the top Poliomyelitis Local Doctors?
Roland W. Sutter
Elite in Poliomyelitis
Roland W. Sutter
Elite in Poliomyelitis
Roland W. Sutter
Geneve, GE, CH 

Roland Sutter practices in Geneve, Switzerland. Mr. Sutter is rated as an Elite expert by MediFind in the treatment of Poliomyelitis. His top areas of expertise are Poliomyelitis, Myelitis, Primary Immunodeficiency (PID), and Common Variable Immune Deficiency.

James E. Lacava
Advanced in Poliomyelitis
Dr. James E. Lacava
Hospital Medicine
Advanced in Poliomyelitis
Dr. James E. Lacava
Hospital Medicine

Bassett Medical Center

1 Atwell Road, 
Cooperstown, NY 
607-547-3456
Languages Spoken:
English
See accepted insurances

. Dr. Lacava is rated as an Advanced provider by MediFind in the treatment of Poliomyelitis. His top areas of expertise are Diabetic Nephropathy, Muscle Invasive Bladder Cancer, Dementia, Endoscopy, and Hip Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Poliomyelitis
Dr. Yvonne Maldonado
Pediatrics
Elite in Poliomyelitis
Dr. Yvonne Maldonado
Pediatrics

Office

300 Pasteur Dr Rm G312, 
Stanford, CA 
650-498-5710
Languages Spoken:
English
See accepted insurances

Yvonne Maldonado is a Pediatrics provider in Stanford, California. Dr. Maldonado is rated as an Elite provider by MediFind in the treatment of Poliomyelitis. Her top areas of expertise are Poliomyelitis, Congenital Toxoplasmosis, Primary Amebic Meningoencephalitis, and Measles.

View All Doctors
What are the latest Poliomyelitis Clinical Trials?
Phase IV Clinical Study Comparing the Immunogenicity and Safety of a Single-dose Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains (sIPV) in Adolescents and Adults Aged 7-50 Years Versus the Primary Immunization With DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
Phase IV Clinical Study Comparing the Immunogenicity and Safety of a Single-dose Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains (sIPV) in Adolescents and Adults Aged 7-50 Years Versus the Primary Immunization With DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
Enrollment Status: Recruiting
Publish Date: January 21, 2026
Intervention Type: Biological
Study Phase: Phase 4

Summary: The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Randomized, Double- Dummy, Observer-Blind Study to Evaluate the Safety and Immunogenicity of Co-administered Novel Live Attenuated Monovalent Oral Poliomyelitis Vaccines in Healthy Young Infants Relative to Monovalent Vaccines Alone in Panama.
A Phase 2, Randomized, Double- Dummy, Observer-Blind Study to Evaluate the Safety and Immunogenicity of Co-administered Novel Live Attenuated Monovalent Oral Poliomyelitis Vaccines in Healthy Young Infants Relative to Monovalent Vaccines Alone in Panama.
Enrollment Status: Recruiting
Publish Date: January 09, 2026
Intervention Type: Biological
Study Phase: Phase 2

Summary: The purpose of this study is to evaluate the safety and tolerability of co-administration of nOPV1 + nOPV2 in infants, relative to those receiving monovalent nOPV vaccines alone and whether two and/or three doses of co-administered nOPV1 and nOPV2 are non-inferior to corresponding doses of nOPV1 alone and nOPV2 alone.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center